Since its establishment, Shanghai Longyao Biotechnology Co., Ltd. has been adhering to the concepts of rigor, innovation, care and service, taking scientific research as the source of life and the foundation of life for the enterprise. The technology transformed in the field and the products developed have a leading advantage in China. Once the products of Longyao Biotechnology were launched, they were favored by medical experts and scholars.
In the golden autumn of October, our company welcomed many hospital experts and scholars to visit and negotiate further cooperation.
On October 27th, Dr. Yu from Shanghai Zhongshan Hospital visited the laboratory. Dr. Li Wei, director of Longyao Biotechnology, accompanied him to visit the laboratory. This is the second visit of Dr. Yu.
On October 29, Director Jiang, Director Xu, Director Ma and Director of Hematology Department of Shanghai Tongren Hospital, accompanied by Ye Shengqin, President of Longyao Biotechnology, and Wang Xin, Assistant President, visited and visited the tumor biological cell therapy technology. In-depth exchanges and discussions were conducted.
On the same day, Huang Qian from Shanghai First People's Hospital was also invited to visit and was introduced by Assistant President Wang Xin.
